ELIZABETH WHEATLEY: Open Payments
NPI 1457591596 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,529 in 53 payments from 12 companies in 2025. Trend: 2023 $310 · 2024 $991 · 2025 $1,529
Food & beverage: $1,306Education: $223
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $306 |
| Teva Pharmaceuticals USA, Inc. | 5 | $300 |
| Neurocrine BioSciences, Inc. | 10 | $261 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $195 |
| Novo Nordisk Inc | 1 | $103 |
| Otsuka America Pharmaceutical, Inc. | 4 | $102 |
| Vanda Pharmaceuticals Inc. | 3 | $85 |
| Lundbeck LLC | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 1 | $46 |
| Axsome Therapeutics, Inc. | 2 | $34 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, ABILIFY ASIMTUFII, AUSTEDO XR, HETLIOZ, REXULTI, SPRAVATO.
Industry payments across VA — which companies pay providers there.
